Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic To Cover AED-Related Liability For Corporate Customers

This article was originally published in The Gray Sheet

Executive Summary

Medtronic will assume liability for claims related to use of its LifePak automatic external defibrillators, removing the most significant barrier to increased corporate sales of the devices, according to the firm

You may also be interested in...



Medtronic AED recall extended

Firm identifies 296 additional monophasic Lifepak 500 automatic external defibrillators for inclusion in voluntary recall, announced in February, of certain monophasic models manufactured in 1997 (1"The Gray Sheet" April 25, 2005, p. 13). Medtronic has shipped upgrades for all of the more than 1,900 devices that originally were recalled and expects to complete upgrades for the rest of the withdrawn products by June. The affected devices may continue to display a "connect electrodes" message or may not analyze the patient's heart rhythm, even when the electrodes are connected properly, Medtronic says. Failure to analyze the patient's heart rhythm inhibits defibrillation...

Medtronic AED recall extended

Firm identifies 296 additional monophasic Lifepak 500 automatic external defibrillators for inclusion in voluntary recall, announced in February, of certain monophasic models manufactured in 1997 (1"The Gray Sheet" April 25, 2005, p. 13). Medtronic has shipped upgrades for all of the more than 1,900 devices that originally were recalled and expects to complete upgrades for the rest of the withdrawn products by June. The affected devices may continue to display a "connect electrodes" message or may not analyze the patient's heart rhythm, even when the electrodes are connected properly, Medtronic says. Failure to analyze the patient's heart rhythm inhibits defibrillation...

HeartSine Samaritan AED Shut-Off Problem Fixed With Software Upgrades

HeartSine Technologies has dispatched software upgrades for roughly 90% of the 672 Samaritan automatic external defibrillators affected by a Class I recall

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021992

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel